Snapshot from Aug 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Picard Medical 1-for-50 Reverse Stock Split
Business reverse stock split

Picard Medical 1-for-50 Reverse Stock Split

Analysis based on 9 articles · First reported Jul 22, 2026 · Last updated Jul 22, 2026

Sentiment
-10
Attention
1
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The reverse stock split is a defensive measure to avoid delisting, reflecting low stock price and potential financial distress. It may temporarily stabilize the stock but does not address underlying business fundamentals.

Medical Devices
Event Summary

Picard Medical, Inc., Inc. (NYSE American: PMI), parent company of SynCardia Systems LLC, announced a 1-for-50 reverse stock split approved by its Board of Directors and stockholders. The split becomes effective July 31, 2026, with trading on a split-adjusted basis starting August 3, 2026. The move aims to maintain compliance with NYSE American listing standards. Fractional shares will be rounded up, and outstanding equity awards and convertible securities will be proportionately adjusted. Richard Fang, Interim CEO and Chairman, stated the split supports continued listing and positions the company for growth.

Key Actions
40 Picard Medical, Inc. approved reverse stock split
Entities Involved
priv
Picard Medical, Inc.
Picard Medical, Inc. is the company executing the reverse stock split to maintain NYSE American listing, indicating financial challenges.
Importance 100.0 Sentiment -20.0
priv
SynCardia Systems
SynCardia is the subsidiary whose artificial heart technology is Picard Medical, Inc.'s core asset; the split does not directly affect its operations.
Importance 50.0 Sentiment -10.0
per
Richard Fang
Richard Fang is Interim CEO and Chairman who announced the reverse stock split and expressed confidence in the company's strategy.
Importance 40.0 Sentiment -10.0
exch
NYSE American
NYSE American is the exchange where Picard Medical, Inc. is listed; the split is intended to meet its continued listing standards.
Importance 30.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
FDA previously approved SynCardia's artificial heart; not directly involved in the stock split.
Importance 10.0 Sentiment 0.0
govactor
Canada — Health Canada
Canada — Health Canada previously approved SynCardia's artificial heart; not directly involved in the stock split.
Importance 10.0 Sentiment 0.0
priv
Continental Stock Transfer & Trust Company
Continental Stock Transfer & Trust Company acts as exchange agent for the reverse stock split.
Importance 10.0 Sentiment 0.0
priv
LifeSci Advisors
LifeSci Advisors is the investor relations firm representing Picard Medical, Inc..
Importance 5.0 Sentiment 0.0
per
Eric Ribner
Eric Ribner is the Managing Director at LifeSci Advisors and contact for investor inquiries.
Importance 5.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ Canada — Health Canada
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.